Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P01178 (oxytocin)
 15,767 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A test situation was developed in which the effects of drugs on habituation of exploratory behavior (head-poke responses) could be assessed independently of their effects on general activity (locomotion and rearing). Habituation, spontaneous recovery from habituation and stimulus specificity of habituation were studied. An amphetamine-barbiturate mixture attenuated habituation of the head-poke response without influencing general activity. Pro-Leu-Gly-NH2 (PLG), an oxytocin fragment, increased locomotor activity and did not alter the course of habituation of the head-poke response. Since exploratory behavior and general activity can be pharmacologically dissociated in the test situation used, it is concluded that the test situation is suitable for studying the effects of drugs on habituation of exploratory behavior. The amphetamine-barbiturate mixture did not influence the stimulus specificity of habituation of the head-poke response. Fenfluramine however increased the effects of stimulus change on the head-poke response while not influencing habituation of this response. These results show that habituation and stimulus specificity of habituation of exploratory behavior can be pharmacologically dissociated.
 ...
PMID:Habituation of the head-poke response: effects of an amphetamine-barbiturate mixture, PLG and fenfluramine. 611 22

Central serotonin (5-HT) and angiotensin (ANG II) stimulate arginine vasopressin (AVP), oxytocin (OT), and adrenocorticotropin (ACTH) secretion and increase blood pressure. Studies were conducted in conscious rats to determine whether neuroendocrine activation by 5-HT requires a brain angiotensinergic intermediate pathway. In the first study, ANG II formation was inhibited by the angiotensin-converting enzyme inhibitor enalapril before injection of the 5-HT releaser/uptake inhibitor d-fenfluramine. Fenfluramine (2 mg/kg ip) stimulated AVP, OT, corticosterone, and prolactin (PRL) secretion (P<0.01). Enalapril (60 mg/l in drinking water for 4 days and 10 mg/kg ip 2 h before the rats were killed) inhibited only the AVP response (P<0.01) to d-fenfluramine. In the second study, the effect of intracerebroventricular injection of the 5-HT2A/2C antagonist LY-53857 (10 microgram), or the ANG II AT1 antagonist DuP-753 (10 microgram), on intracerebroventricular 5-HT (10 microgram)-stimulated AVP, OT, ACTH, PRL, renin secretion, mean arterial pressure (MAP) and heart rate (HR) was tested. LY-53857 inhibited the AVP, OT, and ACTH responses to 5-HT (P<0.01), whereas DuP-753 inhibited only the AVP response (P<0.01). Intraventricular injection of 5-HT increased MAP and decreased HR. The MAP response was not affected by LY-53857 or DuP-753, and at no time did MAP decline below starting levels. The decreased HR was inhibited by LY-53857 but not by DuP-753. These results demonstrate that 5-HT-induced AVP secretion is mediated selectively via brain angiotensinergic mechanisms by way of the AT1 receptor.
 ...
PMID:Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin. 863